Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
Public ClinicalTrials.gov record NCT01355458. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized Double-Blind, Vehicle-Controlled, Parallel Group Study to Demonstrate the Efficacy and Safety of CD07805/47 Gel Applied Topically Once Daily in Subjects With Moderate to Severe Facial Erythema Associated With Rosacea
Study identification
- NCT ID
- NCT01355458
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Galderma R&D
- Industry
- Enrollment
- 260 participants
Conditions and interventions
Conditions
Interventions
- CD07805/47 gel Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2011
- Primary completion
- Aug 31, 2011
- Completion
- Nov 30, 2011
- Last update posted
- Feb 17, 2021
2011
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| University of California, San Francisco | San Francisco | California | 94143 | — |
| Michigan Center for Skin Care Research | Clinton Township | Michigan | 48038 | — |
| Windsor Dermatology | East Windsor | New Jersey | 08520 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| Philadelphia Institute of Dermatology | Fort Washington | Pennsylvania | 19034 | — |
| The Skin Wellness Center | Knoxville | Tennessee | 37922 | — |
| Arlington Center for Dermatology | Arlington | Texas | 76011 | — |
| DermResearch, Inc. | Austin | Texas | 78759 | — |
| Dermatology Treatment & Research Center | Dallas | Texas | 72230 | — |
| The Education & Research Foundation, Inc. | Lynchburg | Virginia | 24501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01355458, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 17, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01355458 live on ClinicalTrials.gov.